CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 63 filers reported holding CTI BIOPHARMA CORP in Q4 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $62 | -54.1% | 14,801 | -34.2% | 0.00% | – |
| Q4 2022 | $135 | -99.9% | 22,489 | -44.3% | 0.00% | – |
| Q3 2022 | $234,000 | -59.0% | 40,371 | -57.9% | 0.00% | -100.0% |
| Q2 2022 | $571,000 | -22.8% | 95,799 | -39.6% | 0.00% | 0.0% |
| Q1 2022 | $740,000 | +264.5% | 158,481 | +93.0% | 0.00% | – |
| Q4 2021 | $203,000 | +968.4% | 82,126 | +1128.0% | 0.00% | – |
| Q1 2021 | $19,000 | – | 6,688 | +411.3% | 0.00% | – |
| Q4 2020 | $0 | – | 1,308 | +1276.8% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 95 | -98.6% | 0.00% | – |
| Q1 2019 | $6,000 | -94.3% | 6,997 | -85.7% | 0.00% | – |
| Q3 2018 | $105,000 | +1650.0% | 48,819 | +3808.6% | 0.00% | – |
| Q2 2018 | $6,000 | +200.0% | 1,249 | +67.7% | 0.00% | – |
| Q2 2017 | $2,000 | – | 745 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 6,535,674 | $27,449,831 | 9.21% |
| Bleichroeder LP | 3,893,730 | $16,353,666 | 3.49% |
| AIGH Capital Management LLC | 2,100,000 | $8,820,000 | 3.25% |
| Ally Bridge Group (NY) LLC | 550,000 | $2,310,000 | 3.03% |
| Ghost Tree Capital, LLC | 2,000,000 | $8,400,000 | 2.48% |
| Bain Capital Life Sciences Investors, LLC | 4,702,996 | $19,753 | 2.47% |
| Altium Capital Management LP | 850,000 | $3,570,000 | 1.98% |
| Parkman Healthcare Partners LLC | 1,753,630 | $7,365,246 | 1.60% |
| BVF INC/IL | 8,813,021 | $37,014,688 | 1.35% |
| Sio Capital Management, LLC | 526,239 | $2,210,204 | 1.09% |